Clinical Trial Update: Hemodynamic Stress Test in Severe Mitral Regurgitation (HEMI)

View source ↗

Summary

The clinical trial update for HEMI evaluates a hemodynamic stress test in patients with severe mitral regurgitation. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Regurgitation

Snippet

Sponsor: Odense University Hospital | Conditions: Mitral Valve Regurgitation | Status: UNKNOWN